Petros Pharmaceuticals, Inc. (PTPI)
PNK · Healthcare · Drug Manufacturers - Specialty & Generic
$0.01
-8.33%
Closing price as of 2026-09-14 · Source: TEK2day Finance
Key Metrics
Market Cap
$233,047.43
Shares Outstanding
42.4M
Exchange
PNK
Currency
USD
About Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | ||||
| Operating Income | (991K) | (391K) | (1.0M) | (989K) |
| Net Income | (923K) | (337K) | (987K) | (956K) |
| Diluted EPS | $-0.03 | N/A | $-0.03 | $-0.30 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 6.0M | 5.8M | 0.00 | 0.00 |
| Gross Profit | 3.7M | 4.2M | 0.00 | 0.00 |
| Operating Income | (15.8M) | (10.8M) | (4.6M) | (4.6M) |
| Net Income | (20.0M) | (8.2M) | (14.3M) | 1.9M |
| Diluted EPS | $-242.00 | $-158.75 | $-83.47 | $-1.56 |